Antibody-Drug Conjugates: New Approaches in Platinum-Resistant Ovarian Cancer

organized by Abbvie

Thursday, February 20, 2025 │ 12:30 – 13:30

Immunotherapy in Endometrial and Cervical Cancer: Innovations and Clinical Insights

organized by MSD

Friday, February 21, 2025 │11:00 – 12:00

PARPi: New Horizons in Patients with Advanced Ovarian Cancer
Bringing Evidence to Patient Care

organized by Pharma&

Friday, February 21, 2025 │ 11:00 – 12:00

Translating Research into Personalized Care for Patients with Advanced Ovarian Cancer

organized by GSK

Friday, February 21, 2025 │ 13:50 – 14:50

Navigating the Complexity of Advanced & Recurrent Endometrial Cancer: Optimizing Management and Treatment of Disease

organized by AstraZeneca

Saturday, February 22, 2025 │ 11:30 – 12:30

Contextualising New First-Line Ovarian Cancer Data: How Will this Impact Personalised Treatment Strategies?

organized by AstraZeneca and MSD

Saturday, February 22, 2025 │ 14:20 – 15:20